No trading signal. This is a routine compliance filing for share plan and dividend reinvestment. Monitor next quarterly results (2.02) or any material 8-K for actionable events.
Price Chart
Executive Summary
GSK filed a routine 6-K reporting PDMR share acquisitions under the company's Share Reward Plan and dividend reinvestment on July 9, 2026. Multiple executives including the CEO, CFO, and other senior leaders acquired small numbers of ordinary shares at ~£19.63, with the largest single purchase being 1,050 shares by a PCA of the Company Secretary. This is a standard administrative disclosure with no material financial or strategic implications.
Key Facts
- CEO Luke Miels acquired 3 ordinary shares via dividend reinvestment at £19.6290.
- CFO Julie Brown acquired 12 ordinary shares (6 partnership + 6 matching) under the Share Reward Plan at £19.6290.
- Largest single transaction: Iain Whyte (PCA of SVP & Company Secretary) acquired 1,050 shares via dividend reinvestment at £19.6297.
- All transactions occurred on July 9, 2026 on the London Stock Exchange.
- Total aggregate value of all reported transactions is approximately £23,000 (based on ~1,170 shares at ~£19.63).
Financial Impact
Negligible — total transaction value ~£23,000 against a $106.9B market cap.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-006623 |
| Document: 0001654954-26-006623-index-headers.html | 0001654954-26-006623 |
| Document: 0001654954-26-006623-index.html | 0001654954-26-006623 |
| Document: 0001654954-26-006623.txt | 0001654954-26-006623 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 6-K | $50.01 $50.22 | ▲ +0.42% | ▼ −0.40% | $47.03 (−5.96%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 11, 2026 21d ago | 6-K | $48.13 $50.22 | ▲ +4.34% | ▲ +4.56% | $47.03 (−2.29%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Aug 26, 2026 5w ago | 6-K | $51.43 $50.44 | ▼ −1.92% | ▼ −1.80% | $47.03 (−8.56%) |
Aug 24, 2026 5w ago | 6-K | $51.78 $50.25 | ▼ −2.95% | ▼ −3.42% | $47.03 (−9.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access